Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Should I buy or sell Ponce PDLB stock today Q4 2025 EPS Tops Views Strategic Education STRA Stock Is It Forming a Base Momentum Building 20260420 Simon Property Group SPG Strategic Expansion Amid Peer Scaling and Shifting Retail REIT Sector Dynamics Stardust Power SDST Stock Trade Alert Trend Weakens 20260420 BEAT Heartbeam leadership cites expanding US cardiac care partnerships as its core nearterm growth priority Dominion Energy Inc D Q1 2026 Earnings Preview Assessing Upside Potential Amid Consensus EPS Decline Expectations What Translational TDACW is doing that smarter investors notice TDACW Earnings Translational Reports Zero Revenue Acquisition Hunt Persists KR Kroger reports 35 percent Q1 2026 EPS beat shares rise modestly in todays trading session The real story behind CareDx CDNA earnings numbers Q1 2026 Better Than Expected Nauticus KITT Q3 2024 Results Miss Estimates EPS 427 vs 006 RH RH Stock Down 199 Support Test at 11468 20260518 Asbury Auto ABG Slides 153 as Selling Pressure Mounts 20260518 HeartSciences HSCSW Stock Consolidating at 006 Next Move Ahead 20260518 Clarivate CLVT Q1 2026 Earnings Surprise EPS 018 Up Significant Is Rezolve AI RZLVW Undervalued at 095 20260520 Banks Increasingly Turn to Apprentices for CostEfficiency and Growth UWM UWMC Q1 2026 Earnings Surprise EPS 008 Up Significant GRDX Q1 2026 Earnings PreRevenue Stage with Widening Losses SILC Q1 2026 Earnings Narrower Loss Than Expected Drives Stock Higher NTB Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Disclosure Stock Edges Lower PETS Q1 2026 Earnings Severe EPS Miss Drives Stock Decline CDRO Q4 2025 Earnings Narrowing Losses but EPS Misses Estimates Sharply Nuveen California AMTFree Municipal Income Fund NKX Climbs 087 Approaches Key Resistance at 1320 Spire Global Surges Over 10 as Momentum Builds Toward Key Resistance Alliant Energy LNT Holds Steady at 7375 Support and Resistance Levels in Focus IGC Pharma IGC Hovers Near Support After Modest Gain Awaiting Breakout MLP Q1 2024 Earnings Net Loss Persists Stock Declines CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue CTVA Q1 2026 Earnings EPS Surges Past Estimates by 254 Shares Edge Higher XOMA Q1 2026 Earnings Significant EPS Miss Amid No Revenue Report UCTT Q1 2026 Earnings EPS Beats Estimates by 16 as Company Delivers Solid Performance GitLab Q1 2026 Earnings EPS Beat Drives Stock Uptick